OR5AR1

Across TCGA pan-cancer cohorts, OR5AR1 RNA is linked to patient survival in 6 of 34 cancer types, making it a survival-associated OR5AR1 data layer compared with 7 for mutation status.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR5AR1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR5AR1 expression acts as an unfavorable survival marker, although some lineages such as SCLC show a favorable association.

STAD, READ, and KIRC are the cancer types where OR5AR1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.172	0.566	<.001	135	view →
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	135	view →
KIRC	OS	Tertile	II,III,IV	0.127	0.806	<.001	72	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
UCEC	OS	Tertile	All	0.602	0.873	.007	36	view →
SCLC	OS	Tertile	All	0.506	0.282	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR5AR1–STAD (DFS)

Open the STAD breakdown →